Effects of breast milk from allergic and non-allergic mothers on mitogen-and allergen-induced cytokine production, 2003, Pediatric Allergy and Immunology, (14), 1, 27-34.
Introduction
The immune system of a new-born baby is not fully developed and it is influenced by maternal immunity, both transplacentally and via the breast-milk. Human milk contains numerous components protecting the infant against infections, e.g.
antibodies, viable lymphocytes, the iron-chelating protein lactoferrin, lysozyme and oligosaccharides (1) . Moreover, several cytokines and chemokines are present in human milk (2) . These factors might influence the maturation of the infant's immune system.
It has been proposed that high concentrations of human milk proteins suppress, while low concentrations enhance, T lymphocyte proliferation (3) . The suppressive effect of breast milk on T lymphocyte proliferation has been suggested to be due to inhibitory effect of milk on the interleukin-2 (IL-2) production from T-cells (4) .
Furthermore, human milk might stimulate cytokine production, e.g. IL-1, IL-3 and IL-6 from peripheral blood mononuclear cells (PBMC) (5) . These studies have been performed using PBMC from adult donors (3) (4) (5) and cells from different cell lines (4) however. Furthermore, the effects on antigen specific responses have not been examined. It has also been suggested that breast-milk cell supernatants can stimulate cord blood lymphocytes (CBL) to produce IgE (6) and IgA (6, 7) antibodies.
Breast-feeding has been proposed to provide protection against otitis media (8) , diarrhoea (9) , acute respiratory infections (10) and invasive Haemophilus influenzae type b infections (11) , even years after ceasing to breast-feed. Breast-fed babies may also have a reduced incidence of conditions with auto-or dysregulated immunity such as Crohn's disease (12) and insulin-dependent diabetes mellitus (13) . Moreover, they have enhanced cell-mediated (14) and humoral (15) immunity after vaccination.
Breast-feeding has also been proposed to enhance IgA antibody synthesis (16) , even if this is controversial (17) . Finally, a long lasting protection of breast-feeding against the development of respiratory allergy has been suggested (18) , even if the protective effect of breast-feeding against development of allergy and atopy is also controversial (19) . Possibly, some of these controversies could be due to individual differences in the composition of breast milk. We have recently shown that allergic mothers have higher levels of IL-4 (20), RANTES and IL-8 (21) in their breast milk than non-allergic mothers. These qualitative differences might affect immunemodulating mechanisms of the breast-milk. In line with this, it has been reported that among children, whose mothers had low IgE levels, breast-feeding was associated with lower levels of total IgE at 6 years of age compared with those who were never breast-fed (22) . In contrast, breast-feeding was associated with higher IgE levels in children whose mothers had high IgE levels. Furthermore, in a study by Allardyce et al, it was shown that breast milk cell supernatants from allergic mothers stimulated higher IgE production by CBL compared to breast milk from non-allergic mothers (6) .
The aim of this study was to analyse the effects of breast milk, on mitogen and allergen induced cytokine production from cord blood mononuclear cells (CBMC), and if those effects differ between allergic and non-allergic mothers.
Material and Methods

Collection and processing of colostrum samples
Colostrum from 22 mothers was collected in sterile plastic tubes using a manual breast-pump within four days after delivery. The samples were immediately frozen and stored at -20°C until analysis. The mothers received verbal information about the aim and design of the study. Sixteen of these mothers participate with their children in a prospective study regarding development of allergy, and an experienced allergy research nurse recorded ongoing or previous typical allergic symptom, i.e. rhinoconjunctivitis, bronchial asthma, and flexural, itchy dermatitis in 8 of these mothers. Their allergic status was confirmed with a screening test for IgE antibodies to a panel of inhalant allergens (Magic Lite SQ Allergy Screen, ALK, Hørsholm, Denmark). The breast milk from these 16 mothers was used to investigate possible differences in the effect of breast milk from allergic and non-allergic mothers.
The breast milk fatty layer and cellular elements were removed by centrifugation at 680 g for 10 min at 4ºC, followed by a second centrifugation of the supernatants at 10 000 g for 30 min at 4ºC. The resulting milk whey was then added to cell cultures as described below. The effect of freezing and centrifugation on the cytokine composition in breast-milk has been evaluated (20) . Centrifugation before or after freezing or different centrifugation protocols did not affect the levels of different cytokines. In samples centrifuged after freezing 88% (median value) (83-96%, ranges) of the IL-10, 89% (78-109%) of the IL-13, 83 (81-97) of the IL-4, 110% (83-125%) of the IFN-γ and 107% (98-112%) of the TGF-β found in samples centrifuged before freezing could be detected. Interleukin-5 could not be detected in the samples used for evaluating the effects of centrifugation before and after freezing.
Cell cultures
Cord blood samples from 30 new-borns were collected in tubes with preservativefree heparin (Beckton Dickinson, Stockholm, Sweden). The families of these infants were randomly invited to participate in this study at the maternity clinic. These infants do not participate in any of our prospective studies and therefore the atopic Cord blood mononuclear cells from four children were stimulated with PHA and cat allergen in the presence of colostrum from their own mothers and colostrum from an "irrelevant" mother. The effect of colostrum on antigen induced cytokine secretion were similar irrespective if the mother and child were "paired" or "unpaired" (data not shown).
ELISA for detection of TGF-β1, IL-4, IL-5, IL-10, IL-13 and IFN-γ
The pg/mL, respectively) in AIM-V medium (Life Technologies) was used as a standards.
50 µL/well of standards, samples, or for controls, AIM-V medium (Life Technologies) only, were added to the plates. For detection, 50 µL/well of biotinylated goat anti-human IFN-γ (0.2 µg/mL) (R&D systems) or rat anti-human IL-5 (1.0 µg/mL) (PharMingen) antibodies were used followed by 50 µL/well of streptavidin conjugated polyhorseradish peroxidase (CLB) diluted 1/10 000 in dilution buffer (CLB). Tetramethylbenzidine (Sigma-Aldrich) was used as substrate, 50 µL/well, and the reaction was stopped by adding 50 µL/well of 1.8 M sulfuric acid. The sensitivity limit for quantitative determinations were 6.2 pg/mL for IL-4, 3.1 pg/mL for IL-5, 4.6 pg/mL for IL-10, 2 pg/mL for IL-13, 25 pg/mL for both IFN-γ assays and 62.5 pg/mL for TGF-β1. Those samples that had a value below the limit for quantitative determinations were assigned a value corresponding to half of that value.
Background responses (cultures with medium only) from mitogen or allergen induced cytokine concentrations, and the cytokine levels in the breast milk samples 
Statistics
As the results were not normally distributed, comparisons between paired groups were analysed using non-parametric Wilcoxon Signed rank test and correlations were analysed with Spearman's rank order correlation coefficient test. A probability level of <5% was considered to be statistically significant. Calculations were performed with a statistical package StatView 5.0 for PC (SAS Institute Inc., Cary, North Carolina, USA).
Ethics
The Regional Ethics Committee for Human Research at the University Hospital of Linköping approved the study.
Results
The cord blood cells were viable after 96 h in culture in the presence of colostrum The effect of breast-milk on PHA (table 1) and allergen (table 2 and The enhancing effect of breast-milk on IL-5, IL-10 and IL-13 production was even more pronounced with the addition of the anti-TGF-β antibody (data not shown).
Interleukin-4 was not detected in these cultures.
Discussion
The inhibited IFN-γ and enhanced IL-10 production by CBMC support that breastmilk is anti-inflammatory (1). The pro-inflammatory cytokine IFN-γ is produced by T helper (Th) 1 cells (24), while IL-10 has immunosuppressive properties (25) . Possibly, these effects of breast-milk could explain the lower incidence of insulin-dependent diabetes mellitus (13) Breast-milk has also been suggested to inhibit IL-2 production from T-cells (4). This cytokine is important for the induction of IFN-γ production. Unpublished data from our laboratory suggest that the IFN-γ production is partially restored when exogenous IL-2 is added to the cell cultures. The inhibition of IFN-γ production was not due to decreased proliferation or low viability of the cells, since most of the cells were viable and proliferated in the presence of diluted colostrum. In cultures with colostrum at 1/2 concentrations, however, most of the cells were dead. This might either be due to that high concentration of TGF-β is cytolytic, or to the presence of other cell death inducing agents in human milk (27) . As several cell types, including mononuclear cells, are present and viable in breast-milk, however, a low concentration of medium would be the most probable explanation to the low viability in cell-cultures with high concentration of colostrum.
Mitogen induced IL-4 production was decreased in the presence of colostrum supporting the hypothesis that breast-feeding protects against allergy. On the other hand, colostrum increased allergen induced IL-5 and IL-13 production. These two cytokines are also associated with atopy. Colostrum also enhanced allergen induced IL-10 production. Recently it was proposed that anti-inflammatory networks, including e.g. IL-10 and TGF-β, might balance the elevated concentrations of IgE and Th2 cytokines in helminth-infected populations with a low prevalence of allergic disease (28) . High levels of TGF-β in breast milk has recently been reported to be associated with a reduced risk for development of IgE mediated cow's milk allergy (29) and to delay the onset of atopic disease (30) . Furthermore, IL-10 is an important factor for the induction of tolerance to specific antigens (31) . Thus, the increased production of allergy associated cytokines IL-5 and IL-13 may be balanced by an enhanced production of anti-inflammatory cytokines such as IL-10 and the high levels of TGF-β present in milk (20) . We have earlier reported higher levels of IL-4 in breast-milk from allergic, as compared to non-allergic, mothers (20) . Interleukin-4 is the most important factor for induction of Th2-cell development and thereby production of Th2-like cytokines (24) .
Earlier studies have indicated that breast-milk from allergic mothers may induce higher IgE levels than breast-milk from non-allergic mothers (6, 22) . No differences on the effect of breast-milk on cytokine production were, however, observed between allergic and non-allergic mothers.
In conclusion, the inhibitory effect of breast milk on IFN-γ production, which was partly due to the high levels of TGF-β, does together with the enhancing effect on IL-10 secretion confirm that breast-milk is anti-inflammatory. Although the allergen induced production of IL-5 and IL-13 was enhanced by colostrum, this was accompanied with an increased production of IL-10. Together with the high levels of TGF-β in breast milk and the inhibitory effect of colostrum on IL-4 production, this suggests a possible mechanism whereby breast-feeding might protect against the development of allergy. Despite differences in the composition of breast milk between allergic and non-allergic mothers, the effects of breast milk on cytokine production from CBMC were independent of the atopic status of the mother. 
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